Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT01207687
Brief Title: Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)

First Submitted : September 1, 2010
First Submitted that Met QC Criteria : September 21, 2010
First Posted : September 23, 2010 (Estimate)

Results First Submitted : May 18, 2017
Results First Submitted that Met QC Criteria : July 17, 2017
Results First Posted : August 17, 2017

Last Update Submitted that Met QC Criteria : July 27, 2018
Last Update Posted : August 27, 2018